National Cancer Institute (NCI)   Report issue

Government Phase 1 Phase 2 Phase 3 Phase 4
Founded: Washington DC United States (1937)

Organization Overview

First Clinical Trial
1977
NCT00427570
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2100

Timeline

NOW
  • Now